Enhabit, Inc. (NYSE:EHAB) Shares Sold by Barclays PLC

Barclays PLC lessened its stake in Enhabit, Inc. (NYSE:EHAB - Free Report) by 74.7% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 79,321 shares of the company's stock after selling 234,757 shares during the quarter. Barclays PLC owned 0.16% of Enhabit worth $627,000 as of its most recent SEC filing.

Other hedge funds have also recently modified their holdings of the company. FMR LLC boosted its holdings in Enhabit by 138.4% during the third quarter. FMR LLC now owns 3,388 shares of the company's stock worth $27,000 after buying an additional 1,967 shares in the last quarter. Quarry LP raised its position in shares of Enhabit by 242.2% in the second quarter. Quarry LP now owns 3,703 shares of the company's stock worth $33,000 after acquiring an additional 2,621 shares during the period. Gladius Capital Management LP boosted its stake in shares of Enhabit by 78.2% during the 3rd quarter. Gladius Capital Management LP now owns 6,259 shares of the company's stock worth $49,000 after acquiring an additional 2,747 shares in the last quarter. Stoneridge Investment Partners LLC acquired a new stake in shares of Enhabit during the 3rd quarter valued at about $81,000. Finally, Canada Pension Plan Investment Board purchased a new position in shares of Enhabit in the 2nd quarter valued at about $93,000.

Insider Transactions at Enhabit

In related news, Director Stuart M. Mcguigan acquired 15,000 shares of Enhabit stock in a transaction that occurred on Tuesday, December 10th. The shares were purchased at an average price of $8.81 per share, for a total transaction of $132,150.00. Following the completion of the transaction, the director now owns 46,810 shares in the company, valued at $412,396.10. This represents a 47.15 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Jeffrey Bolton acquired 4,000 shares of the stock in a transaction on Thursday, December 12th. The shares were bought at an average cost of $8.69 per share, for a total transaction of $34,760.00. Following the purchase, the director now directly owns 98,144 shares of the company's stock, valued at $852,871.36. The trade was a 4.25 % increase in their position. The disclosure for this purchase can be found here. Insiders own 1.90% of the company's stock.

Enhabit Price Performance

EHAB stock traded down $0.06 during trading on Thursday, hitting $7.75. The stock had a trading volume of 249,434 shares, compared to its average volume of 560,555. Enhabit, Inc. has a twelve month low of $6.85 and a twelve month high of $11.74. The company's 50-day moving average price is $7.72 and its two-hundred day moving average price is $8.18. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.46 and a quick ratio of 1.46. The stock has a market capitalization of $389.70 million, a P/E ratio of -3.34 and a beta of 1.89.

Enhabit (NYSE:EHAB - Get Free Report) last issued its quarterly earnings results on Wednesday, November 6th. The company reported $0.03 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.04 by ($0.01). Enhabit had a positive return on equity of 1.67% and a negative net margin of 11.24%. The firm had revenue of $253.60 million during the quarter, compared to analyst estimates of $261.69 million. During the same period in the prior year, the firm earned $0.03 earnings per share. As a group, research analysts predict that Enhabit, Inc. will post 0.22 EPS for the current fiscal year.

Wall Street Analyst Weigh In

EHAB has been the topic of a number of recent analyst reports. Jefferies Financial Group upgraded Enhabit from a "hold" rating to a "buy" rating and increased their price target for the stock from $8.25 to $9.50 in a research report on Monday, December 9th. Leerink Partners reiterated a "market perform" rating and set a $8.00 target price (down previously from $8.50) on shares of Enhabit in a research report on Tuesday, November 19th. One research analyst has rated the stock with a sell rating, four have given a hold rating and one has given a buy rating to the stock. According to MarketBeat, the company currently has an average rating of "Hold" and a consensus price target of $8.75.

About Enhabit

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.